Literature DB >> 17591594

Retinopathy and survival in a population without diabetes: The Beaver Dam Eye Study.

Flavio E Hirai1, Scot E Moss, Michael D Knudtson, Barbara E K Klein, Ronald Klein.   

Abstract

Retinopathy is relatively common in nondiabetic populations, and its long-term prognostic implications are not certain. For this reason, the authors hypothesized that retinal alterations were associated with all-cause and cause-specific mortality in nondiabetic individuals participating in the Beaver Dam Eye Study in Wisconsin. Included in the analysis were 4,294 nondiabetic subjects aged 43-84 years examined at baseline (1988-1990). Retinopathy was classified into four groups by using retinal photographs: 1) no retinopathy, 2) presence of retinal hemorrhages only, 3) presence of retinal microaneurysms only, and 4) presence of moderate or worse retinopathy. The authors analyzed survival during 14 years of follow-up and in 5-year intervals by using time-varying covariates. Baseline prevalence of retinopathy was 7.7%. Adjusting for age, sex, and significant confounders, they observed that moderate retinopathy at baseline was associated with all-cause (hazard ratio = 1.76, 95% confidence interval: 1.16, 2.69) and ischemic heart disease (hazard ratio = 3.17, 95% confidence interval: 1.73, 5.78) mortality after 14 years of follow-up. In the 5-year-interval analysis, the presence of hemorrhages only was significantly related to increased all-cause (hazard ratio = 1.49, 95% confidence interval: 1.05, 2.12) and ischemic heart disease (hazard ratio = 2.43, 95% confidence interval: 1.48, 4.01) mortality. Study results suggest that retinal changes have possible prognostic implications regarding survival of persons without diabetes.

Entities:  

Mesh:

Year:  2007        PMID: 17591594     DOI: 10.1093/aje/kwm126

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

Review 1.  Hypertension-related eye abnormalities and the risk of stroke.

Authors:  Amanda D Henderson; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2011

2.  Retinopathy and CKD as predictors of all-cause and cardiovascular mortality: National Health and Nutrition Examination Survey (NHANES) 1988-1994.

Authors:  Ana C Ricardo; Juan E Grunwald; Sharmila Parvathaneni; Sean Goodin; Alice Ching; James P Lash
Journal:  Am J Kidney Dis       Date:  2014-03-19       Impact factor: 8.860

3.  Retinopathy and mortality. The Beijing Eye Study.

Authors:  Liang Xu; Ya Xing Wang; Xi Wei Xie; Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-02-26       Impact factor: 3.117

4.  Classification of human retinal microaneurysms using adaptive optics scanning light ophthalmoscope fluorescein angiography.

Authors:  Michael Dubow; Alexander Pinhas; Nishit Shah; Robert F Cooper; Alexander Gan; Ronald C Gentile; Vernon Hendrix; Yusufu N Sulai; Joseph Carroll; Toco Y P Chui; Joseph B Walsh; Rishard Weitz; Alfredo Dubra; Richard B Rosen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-04       Impact factor: 4.799

5.  Mortality in Older Persons with Retinopathy and Concomitant Health Conditions: The Age, Gene/Environment Susceptibility-Reykjavik Study.

Authors:  Diana E Fisher; Fridbert Jonasson; Ronald Klein; Palmi V Jonsson; Gudny Eiriksdottir; Lenore J Launer; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2016-04-07       Impact factor: 12.079

6.  Indicators of "healthy aging" in older women (65-69 years of age). A data-mining approach based on prediction of long-term survival.

Authors:  William R Swindell; Kristine E Ensrud; Peggy M Cawthon; Jane A Cauley; Steve R Cummings; Richard A Miller
Journal:  BMC Geriatr       Date:  2010-08-17       Impact factor: 3.921

7.  Estimation of Diabetic Retinal Microaneurysm Perfusion Parameters Based on Computational Fluid Dynamics Modeling of Adaptive Optics Scanning Laser Ophthalmoscopy.

Authors:  Miguel O Bernabeu; Yang Lu; Omar Abu-Qamar; Lloyd P Aiello; Jennifer K Sun
Journal:  Front Physiol       Date:  2018-09-07       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.